{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:19:06Z","timestamp":1769055546610,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,15]]},"DOI":"10.2146\/ajhp110262","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T16:41:29Z","timestamp":1328200889000},"page":"310-320","source":"Crossref","is-referenced-by-count":63,"title":["Comparison of rates of reported adverse events associated with i.v. iron products in the United States"],"prefix":"10.1093","volume":"69","author":[{"given":"George R.","family":"Bailie","sequence":"first","affiliation":[{"name":"Albany Nephrology Pharmacy Group, Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, NY 12208"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041606592810500_b1-0690310","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A randomized, controlled trial comparing iv iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD","volume":"68","author":"Van Wyck","year":"2005","journal-title":"Kidney Int."},{"key":"2019041606592810500_b2-0690310","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ibd.20285","article-title":"Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases","volume":"13","author":"Gasche","year":"2007","journal-title":"Inflamm Bowel Dis."},{"key":"2019041606592810500_b3-0690310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijgo.2007.10.009","article-title":"Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia","volume":"101","author":"Breymann","year":"2008","journal-title":"Int J Gynaecol Obstet."},{"key":"2019041606592810500_b4-0690310","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1067\/mob.2002.121894","article-title":"Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route","volume":"186","author":"Bayoumeu","year":"2002","journal-title":"Am J Obstet Gynecol."},{"key":"2019041606592810500_b5-0690310","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion."},{"key":"2019041606592810500_b6-0690310","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21106","article-title":"Obesity, bariatric surgery, and iron deficiency: true, true, true and related","volume":"83","author":"Love","year":"2008","journal-title":"Am J Hematol."},{"key":"2019041606592810500_b7-0690310","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2006.07.015","article-title":"Intravenous iron alone for the treatment of anemia in patients with chronic heart failure","volume":"48","author":"Bolger","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"2019041606592810500_b8-0690310","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alfa administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"26","author":"Bastit","year":"2008","journal-title":"J Clin Oncol."},{"key":"2019041606592810500_b9-0690310","unstructured":"Rodgers GM Becker PS Bennett CL . National Comprehensive Cancer Network clinical practice guidelines in oncology: cancer- and chemotherapy- induced anemia, V.2.2010. www.nccn.org\/index.asp (accessed 2011 Aug 6)."},{"key":"2019041606592810500_b10-0690310","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N Engl J Med."},{"key":"2019041606592810500_b11-0690310","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alpha in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med."},{"key":"2019041606592810500_b12-0690310","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med."},{"key":"2019041606592810500_b13-0690310","doi-asserted-by":"crossref","first-page":"b4018","DOI":"10.1136\/bmj.b4018","article-title":"Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study","volume":"339","author":"Heinze","year":"2009","journal-title":"BMJ."},{"key":"2019041606592810500_b14-0690310","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jama.2010.206","article-title":"Comparative mortality risk of anemia management practices in incident hemodialysis patients","volume":"303","author":"Brookhart","year":"2010","journal-title":"JAMA."},{"key":"2019041606592810500_b15-0690310","unstructured":"National Institute of Health and Clinical Excellence. Anaemia management in chronic kidney disease: rapid update 2011. www.nice.org.uk\/nicemedia\/live\/13329\/52851\/52851.pdf (accessed 2011 Sep 14)."},{"key":"2019041606592810500_b16-0690310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"2019041606592810500_b17-0690310","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/ndt\/gfh820","article-title":"Hypersensitivity reactions and deaths associated with intravenous iron preparations","volume":"20","author":"Bailie","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"2019041606592810500_b18-0690310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Transplant."},{"key":"2019041606592810500_b19-0690310","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.21794","article-title":"Use of parenteral iron products and serious anaphylactic-type reactions","volume":"85","author":"Wysowski","year":"2010","journal-title":"Am J Hematol."},{"key":"2019041606592810500_b20-0690310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0031-1296198","article-title":"Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America","volume":"61","author":"Bailie","year":"2011","journal-title":"Arzneimittelforschung."},{"key":"2019041606592810500_b21-0690310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(80)90363-0","article-title":"The problem of \u201cprotopathic bias\u201d in case-control studies","volume":"68","author":"Horwitz","year":"1980","journal-title":"Am J Med."},{"key":"2019041606592810500_b22-0690310","first-page":"1","article-title":"Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs","volume-title":"Advances in inflammation research","author":"Weber","year":"1984"},{"key":"2019041606592810500_b23-0690310","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archinternmed.2011.89","article-title":"The FDA drug safety surveillance program: adverse event reporting trends","volume":"171","author":"Weiss-Smith","year":"2011","journal-title":"Arch Intern Med."},{"key":"2019041606592810500_b24-0690310","unstructured":"Medical Dictionary for Regulatory Activities Maintenance and Support Services Organization. MedDRA FAQ. https:\/\/meddramsso.com\/public_faq_meddra.asp (accessed 2011 Sep 15)."},{"key":"2019041606592810500_b25-0690310","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ajh.21154","article-title":"Intravenous iron: from anathema to standard of care","volume":"83","author":"Auerbach","year":"2008","journal-title":"Am J Hematol."},{"key":"2019041606592810500_b26-0690310","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/gfh811","article-title":"Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients","volume":"20","author":"Walters","year":"2005","journal-title":"Nephrol Dial Transplant."},{"key":"2019041606592810500_b27-0690310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2019041606592810500_b28-0690310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood.V1.2.129.129","article-title":"Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia","volume":"1","author":"Goetsch","year":"1946","journal-title":"Blood."},{"key":"2019041606592810500_b29-0690310","first-page":"1439","article-title":"Structure\/histotoxicity relationship of parenteral iron preparations","volume":"42","author":"Geisser","year":"1992","journal-title":"Arzneimittelforschung."},{"key":"2019041606592810500_b30-0690310","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2362.2002.0320s1042.x","article-title":"Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients","volume":"32","author":"Esp\u00f3sito","year":"2002","journal-title":"Eur J Clin Invest."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/4\/310\/28455621\/ajhp0310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T16:54:00Z","timestamp":1593622440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/4\/310\/5112111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,15]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,2,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110262","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2,15]]},"published":{"date-parts":[[2012,2,15]]}}}